Tag: Aptorum Group
Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound...
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on novel therapeutics including the development of next-generation...
Aptorum Group Announces Further Positive Data on SACT-1 Against Neuroblastoma and...
Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics including orphan...
Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and...
Aptorum Group Limited ("Aptorum Group"), a pharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces...
Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and...
Aptorum Group Limited ("Aptorum Group"), a pharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces...
Aptorum Group Announces Significant Progress of Repurposed Drug Candidate, SACT-1 for...
Aptorum Group Limited (Nasdaq: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical...
